Institutional Ownership
Vir Biotechnology Inc
CUSIP 92764N102COMVIRQ1 2026
13D / 13G Filings
31
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
23.0%
Max % of class reported
Institutional Holders
243
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
31 filings · latest Mar 3, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 3, 2026 | Arch Venture Fund Ix, L.P. | 13D/A | 8.5% | — | SEC |
| 2 | Feb 17, 2026 | Sb Investment Advisers (Uk) Limited | 13G/A | 9.4% | 13.12M | SEC |
| 3 | Apr 28, 2025 | Blackrock, Inc. | 13G/A | 10.8% | 14.83M | SEC |
| 4 | Oct 18, 2024 | State Street Corp | 13G/A | 4.1% | 5.63M | SEC |
| 5 | Feb 13, 2024 | Sb Investment Advisers (Uk) Ltd | 13G/A | 12.4% | 16.68M | SEC |
| 6 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.1% | 12.30M | SEC |
| 7 | Jan 24, 2024 | State Street Corp | 13G | 5.1% | — | SEC |
| 8 | Jan 23, 2024 | Blackrock Inc. | 13G/A | 12.5% | 16.86M | SEC |
| 9 | Feb 14, 2023 | Softbank Vision Fund (Aiv M1) L.P. | 13G/A | 15.2% | 20.26M | SEC |
| 10 | Feb 9, 2023 | Vanguard Group Inc | 13G/A | 7.6% | 10.09M | SEC |
21 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Vir Biotechnology Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 18.00M | $161.27M |
| 2 | Arch Venture Management, LLC | 12.92M | $115.73M |
| 3 | Sb Investment Advisers (Uk) Ltd | 10.95M | $98.09M |
| 4 | Gsk PLC | 8.55M | $76.62M |
| 5 | State Street Corp | 7.14M | $63.98M |
| 6 | Goldman Sachs Group Inc | 3.25M | $29.12M |
| 7 | Morgan Stanley | 2.85M | $25.57M |
| 8 | Adar1 Capital Management, LLC | 2.74M | $24.59M |
| 9 | Geode Capital Management, LLC | 2.66M | $23.82M |
| 10 | Dimensional Fund Advisors LP | 2.58M | $23.11M |